comparemela.com
Home
Live Updates
Multiple In Vivo Rodent Disease - Breaking News
Pages:
Latest Breaking News On - Multiple in vivo rodent disease - Page 1 : comparemela.com
Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation
First Preclinical Data for BEAM-302 Demonstrate Increased Levels of Corrected AAT and Reduced Mutant PiZ AAT in Multiple In Vivo Rodent Disease ModelsCAMBRIDGE, Mass., Sept. 07, 2023 Beam.
United states
United kingdom
Chelcie lister
Giuseppe ciaramella
Dan budwick
Beam therapeutics inc
Strategic communications
Exchange commission
First preclinical data
Increased levels
Reduced mutant piz
Multiple in vivo rodent disease
Lung disease
Private securities litigation reform act
Annual report
Quarterly report
vimarsana © 2020. All Rights Reserved.